Related Experiment Videos
Healon in retinal detachment with proliferative vitreoretinopathy
Summary
Intravitreal Healon injections combined with scleral buckling show promise for treating retinal detachments complicated by proliferative vitreoretinopathy (PVR). Success rates varied by PVR grade, with better outcomes in less severe cases.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Vitreoretinal Diseases
Background:
- Proliferative vitreoretinopathy (PVR) is a significant cause of retinal detachment failure after surgery.
- Effective management of complex retinal detachments with PVR remains a clinical challenge.
Purpose of the Study:
- To evaluate the efficacy of intravitreal Healon injections combined with scleral buckling for retinal detachments complicated by PVR.
- To assess the impact of PVR grade on surgical outcomes.
Main Methods:
- A study involving 73 eyes with retinal detachments and PVR treated with scleral buckling and intravitreal Healon injections.
- Postoperative assessment of retinal reattachment at three months.
Main Results:
- Retinal reattachment rates were dependent on PVR grade: 50% for Grade C-1, 30% for Grades C-2, C-3, and D-1.
- No major complications were attributed to Healon injections.
- Failure to achieve reattachment occurred in two cases with extensive, funnel-shaped PVR (Grade D-2).
Conclusions:
- Intravitreal Healon injections with scleral buckling represent an encouraging therapeutic option for retinal detachments with PVR Grades C-2 through D-1.
- The PVR grade is a critical factor influencing the success of this combined treatment approach.